---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-22-000010"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2022-03-28T23:59:59+00:00"
generated_at: "2026-06-26T15:43:24.496881+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Charles River Labs appoints Flavia Pease as CFO; David Smith retires to Senior Advisor

## Summary
- Flavia Pease named Corporate EVP and CFO effective after Q1 2022 10-Q filing (~early May 2022).
- Pease joins from J&J, where she was VP and Group CFO of global Medical Devices ($27B revenue).
- Outgoing CFO David Smith will become Senior Financial Advisor until February 2023.
- Pease receives $600K base salary, 70% target bonus, $2M equity award, plus $1.7M new-hire equity.
- One-time signing bonus of $800,000, with $200K within 30 days and $600K after 12 months.

## SEC filing metadata
- accession: 0001100682-22-000010
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2022-03-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/crl-20220328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-22-000010
- JSON: https://secwatch.observer/filing/0001100682-22-000010.json
- Plain text: https://secwatch.observer/filing/0001100682-22-000010.txt

## Key facts
- Executive change
  Flavia H. Pease was appointed as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
  - Action: appointed
  - Role: Corporate Executive Vice President and Chief Financial Officer
  source text: On March 28, 2022, the Company announced the appointment of Flavia H. Pease as its Corporate Vice President and Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm
- Executive change
  David R. Smith retired as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
  - Action: retired
  - Role: Corporate Executive Vice President and Chief Financial Officer
  source text: Mr. Smith will step down from his position as Corporate Executive Vice President and Chief Financial Officer in connection with Flavia H. Pease’s appointment as the Company’s new Corporate Executive Vice President and Chief Financial Officer (as discussed below).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.